Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic
  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Patterson Companies Reports Fiscal 2023 Fourth Quarter and Year End Operating Results

  • Fourth quarter reported net sales increased 5.0 percent year-over-year to $1.7 billion, and internal sales increased 5.7 percent.
  • Drove adjusted operating margin expansion during the fourth quarter and fiscal 2023 for business overall and across both Dental and Animal Health segments.
  • Returned $156.8 million to shareholders in fiscal 2023 through dividends and share repurchases.
  • Achieved fourth quarter GAAP earnings of $0.77 per diluted share and adjusted earnings1 of $0.84 per diluted share, an increase of 18 percent over prior year.
  • Delivered fiscal 2023 GAAP earnings of $2.12 per diluted share and adjusted earnings of $2.42 per diluted share, an increase of 7 percent compared to prior year.
  • Issues fiscal 2024 GAAP earnings guidance of $2.14 to $2.24 per diluted share and adjusted earnings1 guidance of $2.45 to $2.55 per diluted share.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.72 billion (see attached Sales Summary for further details) in its fiscal fourth quarter ended April 29, 2023, an increase of 5.0 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and contributions from recent acquisitions, increased 5.7 percent over the prior year period.

Reported net income attributable to Patterson Companies, Inc. for the fourth quarter of fiscal 2023 was $75.0 million, or $0.77 per diluted share, compared to $63.9 million, or $0.65 per diluted share, in the fourth quarter of fiscal 2022. Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization and gains on investments, totaled $82.4 million for the fourth quarter of fiscal 2023, or $0.84 per diluted share, compared to $70.4 million, or $0.71 per diluted share, in the fourth quarter of fiscal 2022. The year-over-year increase in reported and adjusted net income attributable to Patterson Companies, Inc. in the fourth quarter of fiscal 2023 is primarily due to increased sales of dental equipment and value-added services and operating margin expansion in both business segments. Both reported and adjusted net income in the fiscal 2023 fourth quarter contained a one-time gain of $3.6 million, or $0.03 per diluted share related to the sale of a real estate asset.

“Patterson had an incredibly strong fourth quarter, concluding a fiscal year in which we achieved our goals of delivering year-over-year internal sales growth and adjusted operating margin expansion for the business overall and across our Dental and Animal Health segments,” said Don Zurbay, President and CEO of Patterson Companies. “Our results demonstrate our team’s outstanding performance throughout fiscal 2023, and the impact of our ongoing initiatives to deepen the value proposition we offer customers and drive margin expansion through improved mix and greater operational efficiency. As we enter fiscal 2024, we remain focused on executing our proven strategy and building upon our momentum to deliver continued growth and value creation.”

Patterson Dental

Reported net sales in the Dental segment for the fourth quarter of fiscal 2023 were $683.5 million. Internal sales increased 8.0 percent compared to the fiscal 2022 fourth quarter. Internal sales of consumables increased 0.3 percent year-over-year, impacted by the continued moderation of infection control products compared to the pandemic-related performance in the year-ago period. Excluding infection control products, internal sales of consumables increased 4.4 percent year-over-year. Compared to the prior year period, internal sales of equipment increased 19.2 percent driven by strength across all product categories. Internal sales of value-added services increased 13.4 percent.

Patterson Animal Health

Reported net sales in the Animal Health segment for the fourth quarter of fiscal 2023 were $1.03 billion. Internal sales growth of 3.2 percent year-over-year was driven by sales growth in the companion animal business. Compared to the prior year period, internal sales of consumables grew 2.4 percent, equipment increased 16.7 percent and value-added services increased 52.6 percent.

Balance Sheet and Capital Allocation

During fiscal 2023, Patterson Companies used $754.9 million of cash from operating activities and collected deferred purchase price receivables of $998.9 million, generating $244.1 million in cash, compared to generating $232.5 million during fiscal 2022. Free cash flow1 (see definition below and attached free cash flow table) during fiscal 2023 declined by $14.4 million compared to the fiscal 2022 period due to an increased level of capital spending during fiscal 2023.

In the fourth quarter of fiscal 2023, Patterson Companies declared a quarterly cash dividend of $0.26 per share and returned $25.4 million in cash dividends to shareholders. Also, under an existing repurchase authorization, the company repurchased approximately 1.5 million shares during the fiscal fourth quarter. At of the end of fiscal 2023, Patterson had approximately $410 million of share repurchase authority remaining on its current share repurchase authorization. During fiscal 2023, Patterson Companies returned $156.8 million to shareholders in the form of cash dividends and share repurchases.

Fiscal 2023 Full Year Results

Consolidated reported net sales for fiscal 2023 totaled $6.5 billion, a 0.4 percent year-over-year decrease. Sales in fiscal 2022 reflected an extra week of sales results in the first quarter of fiscal 2022. Internal sales for fiscal 2023, which are adjusted for the effects of currency translation, the extra week of selling results in the first quarter of fiscal 2022 and contributions from recent acquisitions, increased 2.9 percent year-over-year. Fiscal 2023 Dental segment internal sales increased 1.3 percent, including a 2.1 percent decline in consumables, a 4.9 percent increase in equipment and an 8.1 percent increase in value-added services. Fiscal 2023 Animal Health segment internal sales increased 3.4 percent, including 3.1 percent growth in consumables, 6.8 percent growth in equipment and a 24.4 percent increase in value-added services.

Reported net income attributable to Patterson Companies, Inc. in fiscal 2023 was $207.6 million, or $2.12 per diluted share, compared to $203.2 million, or $2.06 per diluted share in fiscal 2022. Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization, integration and business restructuring expenses, legal reserves, inventory donation charges and gains on investments totaled $236.4 million in fiscal 2023, or $2.42 per diluted share, compared to $223.7 million, or $2.27 per diluted share in the prior year.

Fiscal 2024 Guidance

Patterson Companies today initiated its fiscal 2024 earnings guidance, which is provided on both a GAAP and non-GAAP adjusted1 basis:

  • GAAP earnings are expected to be in the range of $2.14 to $2.24 per diluted share.
  • Non-GAAP adjusted earnings1 are expected to be in the range of $2.45 to $2.55 per diluted share.
  • Our non-GAAP adjusted earnings1 guidance excludes the after-tax impact of:
    • Deal amortization expenses of approximately $29.3 million ($0.31 per diluted share).

Our guidance reflects the strength of our business and competitive positioning, as well as our expectations for the North American and international end markets in which we operate, which we expect to be affected by the ongoing challenges of inflationary trends and higher interest rates as well as a potential slow-down in the broader economy. Beyond macroeconomic and geopolitical uncertainty, our guidance further assumes that there are no material adverse developments associated with wide-spread public health concerns.

1Non-GAAP Financial Measures

The Reconciliation of GAAP to non-GAAP Measures table appearing behind the accompanying financial information is provided to adjust reported GAAP measures, namely operating income, other income (expense), net income before taxes, income tax expense, net income, net income attributable to Patterson Companies, Inc. and diluted earnings per share attributable to Patterson Companies, Inc., for the impact of deal amortization, integration and business restructuring expenses, legal reserves, inventory donation charges and gains on investments along with the related tax effects of these items.

The term “free cash flow” used in this release is defined as net cash used in operating activities less capital expenditures plus the collection of deferred purchase price receivables.

In addition, the term “internal sales” used in this release represents net sales adjusted to exclude the impact of foreign currency, the extra week of selling results in the first quarter of fiscal 2022 and the impact from recent acquisitions. Foreign currency impact represents the difference in results that is attributable to fluctuations in currency exchange rates the company uses to convert results for all foreign entities where the functional currency is not the U.S. dollar. The company calculates the impact as the difference between the current period results translated using the current period currency exchange rates and using the comparable prior period's currency exchange rates. The company believes the disclosure of net sales changes in constant currency provides useful supplementary information to investors in light of fluctuations in currency rates.

Management believes that these non-GAAP measures may provide a helpful representation of the company's fourth quarter performance and enable comparison of financial results between periods where certain items may vary independent of business performance. These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding, similarly captioned, GAAP measures.

Fourth Quarter Conference Call and Replay

Patterson Companies’ fiscal 2023 fourth quarter conference call will start at 8:30 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on the Patterson Companies website. A replay of the fiscal 2023 fourth quarter conference call can be heard for one week at 1-800-770-2030 and by providing the Conference ID 71954 when prompted.

About Patterson Companies Inc.

Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain is equaled only by our dedicated, knowledgeable people who deliver unrivalled expertise and unmatched customer service and support.

Learn more: pattersoncompanies.com

This press release contains, and our officers and representatives may from time to time make, certain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding future financial performance, and the objectives and expectations of management. Forward-looking statements often include words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “seeks” or words of similar meaning, or future or conditional verbs, such as “will,” “should,” “could” or “may.”

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements.

Any number of factors could affect our actual results and cause such results to differ materially from those contemplated by any forward-looking statements, including, but not limited to, the following: wide-spread public health concerns as we experienced, and may continue to experience, with the COVID-19 pandemic; our dependence on suppliers to manufacture and supply substantially all of the products we sell; potential disruption of distribution capabilities, including service issues with third-party shippers; our dependence on relationships with sales representatives and service technicians to retain customers and develop business; adverse changes in supplier rebates or other purchasing incentives; risks of selling private label products, including the risk of adversely affecting our relationships with suppliers; the risk of technological and market obsolescence for the products we sell; the risk of failing to innovate and develop new and enhanced software and e-services products; our dependence on positive perceptions of Patterson’s reputation; risks associated with illicit human use of pharmaceutical products we distribute; risks inherent in acquiring and disposing of assets or other businesses and risks inherent in integrating acquired businesses; turnover or loss of key personnel or highly skilled employees; risks associated with information systems, software products and cyber-security attacks; risks related to climate change; our ability to comply with restrictive covenants and other limits in our credit agreement; the risk that our governing documents and Minnesota law may discourage takeovers and business combinations; the effects of the highly competitive dental and animal health supply markets in which we compete; the effects of consolidation within the dental and animal health supply markets; exposure to the risks of the animal production business, including changing consumer demand, the cyclical livestock market, weather conditions, the availability of natural resources and other factors outside our control, and the risks of the companion animal business, including the possibility of disease adversely affecting the pet population; exposure to the risks of the health care industry, including changes in demand due to political, economic and regulatory influences and other factors outside our control; increases in over-the-counter sales and e-commerce options; risks from the formation or expansion of GPOs, provider networks and buying groups that may place us at a competitive disadvantage; risks of litigation and government inquiries and investigations, including the diversion of management’s attention, the cost of defending against such actions, the possibility of damage awards or settlements, fines or penalties, or equitable remedies (including but not limited to the revocation of or non-renewal of licenses) and inherent uncertainty; failure to comply with health care fraud or other laws and regulations; change and uncertainty in the health care industry; failure to comply with existing or future U.S. or foreign laws and regulations including those governing the distribution of pharmaceuticals and controlled substances; failure to comply with evolving data privacy laws and regulations; tax legislation; risks inherent in international operations, including currency fluctuations; and uncertain macro-economic conditions, including inflationary pressures.

The order in which these factors appear should not be construed to indicate their relative importance or priority. We caution that these factors may not be exhaustive, accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results.

You should carefully consider these and other relevant factors, including those risk factors in Part I, Item 1A, (“Risk Factors”) in our most recent Form 10-K and information which may be contained in our other filings with the U.S. Securities and Exchange Commission, or SEC, when reviewing any forward-looking statement.

Investors should understand it is impossible to predict or identify all such factors or risks. As such, you should not consider the foregoing list, or the risks identified in our SEC filings, to be a complete discussion of all potential risks or uncertainties.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We do not undertake any obligation to release publicly any revisions to any forward-looking statements whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

Three Months Ended

 

Twelve Months Ended

 

April 29,

2023

 

April 30,

2022

 

April 29,

2023

 

April 30,

2022

 

 

 

 

 

 

 

 

Net sales

$

1,721,152

 

 

$

1,638,772

 

 

$

6,471,471

 

 

$

6,499,405

 

 

 

 

 

 

 

 

 

Gross profit

 

389,761

 

 

 

348,239

 

 

 

1,372,945

 

 

 

1,289,087

 

 

 

 

 

 

 

 

 

Operating expenses

 

284,651

 

 

 

275,401

 

 

 

1,096,974

 

 

 

1,132,085

 

 

 

 

 

 

 

 

 

Operating income

 

105,110

 

 

 

72,838

 

 

 

275,971

 

 

 

157,002

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

Gains on investments

 

 

 

 

890

 

 

 

 

 

 

101,809

 

Other income, net

 

4,747

 

 

 

13,318

 

 

 

27,826

 

 

 

27,731

 

Interest expense

 

(10,798

)

 

 

(4,693

)

 

 

(33,636

)

 

 

(20,288

)

 

 

 

 

 

 

 

 

Income before taxes

 

99,059

 

 

 

82,353

 

 

 

270,161

 

 

 

266,254

 

 

 

 

 

 

 

 

 

Income tax expense

 

24,217

 

 

 

18,954

 

 

 

63,563

 

 

 

64,540

 

 

 

 

 

 

 

 

 

Net income

 

74,842

 

 

 

63,399

 

 

 

206,598

 

 

 

201,714

 

Net loss attributable to noncontrolling interests

 

(123

)

 

 

(479

)

 

 

(959

)

 

 

(1,496

)

Net income attributable to Patterson Companies, Inc.

$

74,965

 

 

$

63,878

 

 

$

207,557

 

 

$

203,210

 

 

 

 

 

 

 

 

 

Earnings per share attributable to Patterson Companies, Inc.:

 

 

 

 

 

 

 

Basic

$

0.77

 

 

$

0.66

 

 

$

2.14

 

 

$

2.09

 

 

 

 

 

 

 

 

 

Diluted

$

0.77

 

 

$

0.65

 

 

$

2.12

 

 

$

2.06

 

 

 

 

 

 

 

 

 

Weighted average shares:

 

 

 

 

 

 

 

Basic

 

97,224

 

 

 

97,476

 

 

 

97,027

 

 

 

97,277

 

Diluted

 

97,768

 

 

 

98,680

 

 

 

97,815

 

 

 

98,514

 

 

 

 

 

 

 

 

 

Dividends declared per common share

$

0.26

 

 

$

0.26

 

 

$

1.04

 

 

$

1.04

 

 

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

April 29,

2023

 

April 30,

2022

 

 

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

159,669

 

$

142,014

Receivables, net

 

477,384

 

 

447,162

Inventory

 

795,072

 

 

785,604

Prepaid expenses and other current assets

 

351,011

 

 

304,242

Total current assets

 

1,783,136

 

 

1,679,022

Property and equipment, net

 

212,283

 

 

213,140

Operating lease right-of-use assets, net

 

92,956

 

 

70,722

Goodwill and identifiable intangibles, net

 

388,293

 

 

393,244

Investments

 

160,022

 

 

139,182

Long-term receivables, net and other

 

242,456

 

 

246,320

Total assets

$

2,879,146

 

$

2,741,630

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

724,993

 

$

681,321

Other accrued liabilities

 

250,949

 

 

276,000

Operating lease liabilities

 

28,390

 

 

29,348

Current maturities of long-term debt

 

36,000

 

 

Borrowings on revolving credit

 

45,000

 

 

29,000

Total current liabilities

 

1,085,332

 

 

1,015,669

Long-term debt

 

451,231

 

 

488,554

Non-current operating lease liabilities

 

67,376

 

 

43,332

Other non-current liabilities

 

156,672

 

 

151,440

Total liabilities

 

1,760,611

 

 

1,698,995

Stockholders' equity

 

1,118,535

 

 

1,042,635

Total liabilities and stockholders' equity

$

2,879,146

 

$

2,741,630

 

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

Twelve Months Ended

 

April 29,

2023

 

April 30,

2022

 

 

 

 

Operating activities:

 

 

 

Net income

$

206,598

 

 

$

201,714

 

Adjustments to reconcile net income to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

83,704

 

 

 

81,992

 

Gains on investments

 

 

 

 

(101,809

)

Non-cash employee compensation

 

15,543

 

 

 

23,805

 

Non-cash losses (gains) and other, net

 

654

 

 

 

(1,431

)

Change in assets and liabilities:

 

 

 

Receivables

 

(1,047,075

)

 

 

(1,144,833

)

Inventory

 

(11,086

)

 

 

(53,871

)

Accounts payable

 

43,095

 

 

 

80,904

 

Accrued liabilities

 

(21,714

)

 

 

(27,630

)

Other changes from operating activities, net

 

(24,571

)

 

 

(39,835

)

Net cash used in operating activities

 

(754,852

)

 

 

(980,994

)

Investing activities:

 

 

 

Additions to property and equipment and software

 

(64,220

)

 

 

(38,308

)

Collection of deferred purchase price receivables

 

998,912

 

 

 

1,213,497

 

Payments related to acquisitions, net of cash acquired

 

(33,280

)

 

 

(19,793

)

Payments related to investments

 

(15,000

)

 

 

 

Sale of investments

 

 

 

 

75,942

 

Other investing activities

 

15,155

 

 

 

7,690

 

Net cash provided by investing activities

 

901,567

 

 

 

1,239,028

 

Financing activities:

 

 

 

Dividends paid

 

(101,346

)

 

 

(101,111

)

Repurchases of common stock

 

(55,492

)

 

 

(35,000

)

Payments on long-term debt

 

(1,500

)

 

 

(100,750

)

Draw (payment) on revolving credit

 

16,000

 

 

 

(24,000

)

Other financing activities

 

15,854

 

 

 

7,627

 

Net cash used in financing activities

 

(126,484

)

 

 

(253,234

)

Effect of exchange rate changes on cash

 

(2,576

)

 

 

(6,030

)

Net change in cash and cash equivalents

 

17,655

 

 

 

(1,230

)

Cash and cash equivalents at beginning of period

 

142,014

 

 

 

143,244

 

Cash and cash equivalents at end of period

$

159,669

 

 

$

142,014

 

 

PATTERSON COMPANIES, INC.

SALES SUMMARY

(Dollars in thousands)

(Unaudited)

 

April 29,

2023

 

April 30,

2022

 

Total

Sales

Growth

 

Foreign

Exchange

Impact

 

53rd Week

 

Acquisition Impact

 

Internal

Sales Growth

Three Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated net sales

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

1,333,446

 

$

1,324,427

 

 

0.7

%

 

(1.3

) %

 

%

 

0.2

%

 

1.8

%

Equipment

 

279,901

 

 

236,713

 

 

18.2

 

 

(0.6

)

 

 

 

 

 

18.8

 

Value-added services and other

 

107,805

 

 

77,632

 

 

38.9

 

 

(1.3

)

 

 

 

7.0

 

 

33.2

 

Total

$

1,721,152

 

$

1,638,772

 

 

5.0

%

 

(1.2

) %

 

%

 

0.5

%

 

5.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dental

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

353,295

 

$

354,255

 

 

(0.3

) %

 

(0.6

) %

 

%

 

%

 

0.3

%

Equipment

 

246,820

 

 

208,357

 

 

18.5

 

 

(0.7

)

 

 

 

 

 

19.2

 

Value-added services and other

 

83,391

 

 

73,805

 

 

13.0

 

 

(0.4

)

 

 

 

 

 

13.4

 

Total

$

683,506

 

$

636,417

 

 

7.4

%

 

(0.6

) %

 

%

 

%

 

8.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Animal Health

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

980,151

 

$

970,172

 

 

1.0

%

 

(1.6

) %

 

%

 

0.2

%

 

2.4

%

Equipment

 

33,081

 

 

28,356

 

 

16.7

 

 

 

 

 

 

 

 

16.7

 

Value-added services and other

 

18,946

 

 

9,315

 

 

103.4

 

 

(7.4

)

 

 

 

58.2

 

 

52.6

 

Total

$

1,032,178

 

$

1,007,843

 

 

2.4

%

 

(1.6

) %

 

%

 

0.8

%

 

3.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

 

 

 

 

 

 

 

 

 

Value-added services and other

$

5,468

 

$

(5,488

)

 

199.6

%

 

%

 

%

 

%

 

199.6

%

Total

$

5,468

 

$

(5,488

)

 

199.6

%

 

%

 

%

 

%

 

199.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PATTERSON COMPANIES, INC.

SALES SUMMARY

(Dollars in thousands)

(Unaudited)

 

April 29,

2023

 

April 30,

2022

 

Total

Sales

Growth

 

Foreign

Exchange

Impact

 

53rd Week

 

Acquisition Impact

 

Internal

Sales Growth

Twelve Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated net sales

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

5,147,330

 

$

5,248,040

 

(1.9

) %

 

(1.9

) %

 

(1.9

) %

 

0.1

%

 

1.8

%

Equipment

 

950,403

 

 

920,424

 

3.3

 

 

(0.6

)

 

(1.4

)

 

 

 

5.3

 

Value-added services and other

 

373,738

 

 

330,941

 

12.9

 

 

(1.5

)

 

(1.7

)

 

1.8

 

 

14.3

 

Total

$

6,471,471

 

$

6,499,405

 

(0.4

) %

 

(1.7

) %

 

(1.8

) %

 

0.2

%

 

2.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dental

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

1,358,823

 

$

1,424,677

 

(4.6

) %

 

(0.6

) %

 

(1.9

) %

 

%

 

(2.1

) %

Equipment

 

823,978

 

 

800,144

 

3.0

 

 

(0.6

)

 

(1.3

)

 

 

 

4.9

 

Value-added services and other

 

309,341

 

 

291,311

 

6.2

 

 

(0.4

)

 

(1.5

)

 

 

 

8.1

 

Total

$

2,492,142

 

$

2,516,132

 

(1.0

) %

 

(0.6

) %

 

(1.7

) %

 

%

 

1.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Animal Health

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

3,788,507

 

$

3,823,363

 

(0.9

) %

 

(2.4

) %

 

(1.8

) %

 

0.2

%

 

3.1

%

Equipment

 

126,425

 

 

120,280

 

5.1

 

 

 

 

(1.7

)

 

 

 

6.8

 

Value-added services and other

 

49,990

 

 

39,231

 

27.4

 

 

(9.9

)

 

(2.7

)

 

15.6

 

 

24.4

 

Total

$

3,964,922

 

$

3,982,874

 

(0.5

) %

 

(2.4

) %

 

(1.8

) %

 

0.3

%

 

3.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

 

 

 

 

 

 

 

 

 

Value-added services and other

$

14,407

 

$

399

 

3,510.8

%

 

%

 

%

 

%

 

3,510.8

%

Total

$

14,407

 

$

399

 

3,510.8

%

 

%

 

%

 

%

 

3,510.8

%

 

PATTERSON COMPANIES, INC.

OPERATING INCOME BY SEGMENT

(In thousands)

(Unaudited)

 

Three Months Ended

 

Twelve Months Ended

 

April 29,

2023

 

April 30,

2022

 

April 29,

2023

 

April 30,

2022

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

 

 

 

 

 

Dental

$

79,121

 

 

$

61,603

 

 

$

237,268

 

 

$

180,212

 

Animal Health

 

46,622

 

 

 

41,043

 

 

 

126,994

 

 

 

114,403

 

Corporate

 

(20,633

)

 

 

(29,808

)

 

 

(88,291

)

 

 

(137,613

)

Total

$

105,110

 

 

$

72,838

 

 

$

275,971

 

 

$

157,002

 

 

PATTERSON COMPANIES, INC.

RECONCILIATION OF GAAP TO NON-GAAP MEASURES

(Dollars in thousands, except per share amounts)

(Unaudited)

For the three months ended April 29, 2023

 

GAAP

 

Deal amortization

 

Integration and business restructuring expenses

 

Legal reserves

 

Inventory donation charges

 

Gains on investments

 

Non-GAAP

Operating income

 

$

105,110

 

 

$

9,772

 

$

 

$

 

$

 

$

 

 

$

114,882

 

Other income (expense), net

 

 

(6,051

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,051

)

Income before taxes

 

 

99,059

 

 

 

9,772

 

 

 

 

 

 

 

 

 

 

 

108,831

 

Income tax expense

 

 

24,217

 

 

 

2,337

 

 

 

 

 

 

 

 

 

 

 

26,554

 

Net income

 

 

74,842

 

 

 

7,435

 

 

 

 

 

 

 

 

 

 

 

82,277

 

Net loss attributable to noncontrolling interests

 

 

(123

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(123

)

Net income attributable to Patterson Companies, Inc.

 

$

74,965

 

 

$

7,435

 

$

 

$

 

$

 

$

 

 

$

82,400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Patterson Companies, Inc.*

 

$

0.77

 

 

$

0.08

 

$

 

$

 

$

 

$

 

 

$

0.84

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income as a % of sales

 

 

6.1

%

 

 

 

 

 

 

 

 

 

 

 

 

6.7

%

Effective tax rate

 

 

24.4

%

 

 

 

 

 

 

 

 

 

 

 

 

24.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended April 30, 2022

 

GAAP

 

Deal amortization

 

Integration and business restructuring expenses

 

Legal reserves

 

Inventory donation charges

 

Gains on investments

 

Non-GAAP

Operating income

 

$

72,838

 

 

$

9,405

 

$

 

$

 

$

 

$

 

 

$

82,243

 

Other income (expense), net

 

 

9,515

 

 

 

 

 

 

 

 

 

 

 

(890

)

 

 

8,625

 

Income before taxes

 

 

82,353

 

 

 

9,405

 

 

 

 

 

 

 

 

(890

)

 

 

90,868

 

Income tax expense

 

 

18,954

 

 

 

2,237

 

 

 

 

 

 

 

 

(227

)

 

 

20,964

 

Net income

 

 

63,399

 

 

 

7,168

 

 

 

 

 

 

 

 

(663

)

 

 

69,904

 

Net loss attributable to noncontrolling interests

 

 

(479

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(479

)

Net income attributable to Patterson Companies, Inc.

 

$

63,878

 

 

$

7,168

 

$

 

$

 

$

 

$

(663

)

 

$

70,383

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Patterson Companies, Inc.*

 

$

0.65

 

 

$

0.07

 

$

 

$

 

$

 

$

(0.01

)

 

$

0.71

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income as a % of sales

 

 

4.4

%

 

 

 

 

 

 

 

 

 

 

 

 

5.0

%

Effective tax rate

 

 

23.0

%

 

 

 

 

 

 

 

 

 

 

 

 

23.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* May not sum due to rounding.

 

PATTERSON COMPANIES, INC.

RECONCILIATION OF GAAP TO NON-GAAP MEASURES

(Dollars in thousands, except per share amounts)

(Unaudited)

For the twelve months ended April 29, 2023

 

GAAP

 

Deal amortization

 

Integration and business restructuring expenses

 

Legal reserves

 

Inventory donation charges

 

Gains on investments

 

Non-GAAP

Operating income

 

$

275,971

 

 

$

37,932

 

$

 

$

 

$

 

$

 

 

$

313,903

 

Other income (expense), net

 

 

(5,810

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,810

)

Income before taxes

 

 

270,161

 

 

 

37,932

 

 

 

 

 

 

 

 

 

 

 

308,093

 

Income tax expense

 

 

63,563

 

 

 

9,083

 

 

 

 

 

 

 

 

 

 

 

72,646

 

Net income

 

 

206,598

 

 

 

28,849

 

 

 

 

 

 

 

 

 

 

 

235,447

 

Net loss attributable to noncontrolling interests

 

 

(959

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(959

)

Net income attributable to Patterson Companies, Inc.

 

$

207,557

 

 

$

28,849

 

$

 

$

 

$

 

$

 

 

$

236,406

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Patterson Companies, Inc.*

 

$

2.12

 

 

$

0.29

 

$

 

$

 

$

 

$

 

 

$

2.42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income as a % of sales

 

 

4.3

%

 

 

 

 

 

 

 

 

 

 

 

 

4.9

%

Effective tax rate

 

 

23.5

%

 

 

 

 

 

 

 

 

 

 

 

 

23.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the twelve months ended April 30, 2022

 

GAAP

 

Deal amortization

 

Integration and business restructuring expenses

 

Legal reserves

 

Inventory donation charges

 

Gains on investments

 

Non-GAAP

Operating income

 

$

157,002

 

 

$

37,812

 

$

4,245

 

$

36,000

 

$

49,194

 

$

 

 

$

284,253

 

Other income (expense), net

 

 

109,252

 

 

 

 

 

 

 

 

 

 

 

(101,809

)

 

 

7,443

 

Income before taxes

 

 

266,254

 

 

 

37,812

 

 

4,245

 

 

36,000

 

 

49,194

 

 

(101,809

)

 

 

291,696

 

Income tax expense

 

 

64,540

 

 

 

8,990

 

 

1,061

 

 

8,460

 

 

12,308

 

 

(25,896

)

 

 

69,463

 

Net income

 

 

201,714

 

 

 

28,822

 

 

3,184

 

 

27,540

 

 

36,886

 

 

(75,913

)

 

 

222,233

 

Net loss attributable to noncontrolling interests

 

 

(1,496

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,496

)

Net income attributable to Patterson Companies, Inc.

 

$

203,210

 

 

$

28,822

 

$

3,184

 

$

27,540

 

$

36,886

 

$

(75,913

)

 

$

223,729

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Patterson Companies, Inc.*

 

$

2.06

 

 

$

0.29

 

$

0.03

 

$

0.28

 

$

0.37

 

$

(0.77

)

 

$

2.27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income as a % of sales

 

 

2.4

%

 

 

 

 

 

 

 

 

 

 

 

 

4.4

%

Effective tax rate

 

 

24.2

%

 

 

 

 

 

 

 

 

 

 

 

 

23.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* May not sum due to rounding.

 

PATTERSON COMPANIES, INC.

FREE CASH FLOW

(In thousands)

(Unaudited)

 

Twelve Months Ended

 

April 29,

2023

 

April 30,

2022

 

 

 

 

Net cash used in operating activities

$

(754,852

)

 

$

(980,994

)

Additions to property and equipment and software

 

(64,220

)

 

 

(38,308

)

Collection of deferred purchase price receivables

 

998,912

 

 

 

1,213,497

 

Free cash flow

$

179,840

 

 

$

194,195

 

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.